2012 ACR/ARHP Annual Meeting

November 9-14, 2012. Washington, DC.

View by Title View Sessions

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Abstract Number: 2522

M-Ficolin, an Activator of the Complement System, Is the Strongest Predictor of Both DAS28 Remission and Low Disease Activity in a Cohort of 180 Early DMARD Naïve Rheumatoid Arthritis Patients Followed in the Opera-Study
Abstract Number: 1798

Macrophage Migration Inhibitory Factor Regulates Dual-Specificity Phosphatases Via Glucocorticoid Induced Leucine Zipper
Abstract Number: 1800

Macrophages in Hypoxic Rheumatoid Joints Preferentially Express Hypoxia Inducible Transcription Factor-2
Abstract Number: 1037

Magnetic Resonance Imaging (MRI) Assessment of Inflammatory Myopathy: Quantitative Fat-Corrected Muscle T2 and Conventional T2 Measurement Versus Standard MRI and Clinical Metrics
Abstract Number: 1021

Magnetic Resonance Imaging in Follow-up of Clinical Remission in Juvenile Idiopathic Arthritis
Abstract Number: 1051

Magnetic Resonance Imaging in Inflammatory Bowel Disease Patients with Arthralgia
Abstract Number: 2034

Magnetic Resonance Imaging Is a Reliable Tool to Monitor Chronic Non-Bacterial Osteomyelitis in Children
Abstract Number: 2488

Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
Abstract Number: 2585

Magnetic Resonance Imaging Versus Dual Energy Computed Tomography for Detection of Joint Pathology in Gout
Abstract Number: 2142

Magnetic Resonance Imaging-Proven Osteitis At Baseline Predicts the Early Rheumatoid Arthritis Patients Who Will Develop Rapid Radiographic Progression: MRI Is Beneficial to Find the Window of Opportunity in Early RA
Abstract Number: 2221

Major Adverse Cardiovascular Events Are More Common in Rheumatoid Arthritis Than in Psoriatic Arthritis and Are Associated with Different Risk Factors
Abstract Number: 1437

Majority of Lupusqol Domains Are Negatively Correlated with Systemic Lupus Activity Questionnaire (SLAQ) Score
Abstract Number: 151

Management of Gout Attacks in the Community
Abstract Number: 2580

Marginal Zone Defects in Wiskott-Aldrich Syndrome Are Dependent On B Cell Intrinsic Toll-Like Receptor Signals
Abstract Number: 668

Markers of Nitric Oxide and Hydroxyl Radical Formation Are Increased in Proliferative Lupus Nephritis and May Emanate From Increased Nitric Oxide Synthase and NADPH Oxidase Production and Reduced Endothelial Nitric Oxide Synthase-Derived NO Scavenging
Abstract Number: 735

Mass Spectrometry Assays of Plasma Biomarkers to Predict Radiographic Progression of Knee Osteoarthritis
Abstract Number: 2046

Matching of Patients’ Actual and Desired Roles in Treatment Decision Making and Trust in Physicians
Abstract Number: 1794

Matrix Metalloproteinase 3 and Acute Phase Proteins As Markers of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
Abstract Number: 2128

Matrix Metalloproteinase 3: A Biomarker of Disease Activity in Rheumatoid Arthritis
Abstract Number: 247

Meager Depression Screening and Mental Health Referral Rates for Patients with Arthritis in a National Sample
Abstract Number: 324

Measurement and Evaluation of Isotypes of Anti-Citrullinated Fibrinogen and Anti-Citrullinated Alpha-Enolase Antibodies in Juvenile Idiopathic Arthritis Patients
Abstract Number: 721

Measurement of Pulmonary Arteries by Cardiac Magnetic Resonance Imaging: A Simple and Useful Tool for the Detection of Pulmonary Hypertension in Systemic Sclerosis Patients without Overt Cardiac Microvascular Perfusion Defects or Fibrosis
Abstract Number: 1450

MEDI-551 Depletes a Majority of Murine B Cells and Reduces Serum Titers of Autoantibodies in the SLE1-huCD19 TG Mice
Abstract Number: 1032

Medial Meniscal Root Tears and the Association with Meniscal Extrusion, Prevalent Cartilage Damage and Longitudinal Cartilage Loss: The MOST Study
Abstract Number: 249

Medial Subchondral Bone Marrow Lesions Increase the Odds of Knee Joint Replacement – Data From the Osteoarthritis Initative
Abstract Number: 932

Medical Costs and Health Care Resource Use in Patients with Systemic Lupus Erythematosus in an Insured Population
Abstract Number: 94

Medical Costs and Health Care Resource Use in Patients with Systemic Sclerosis in an Insured Population
Abstract Number: 2028

Medication Adherence and Quality of Life in Children with Rheumatic Disease
Abstract Number: 387

Medication Choices and Medication Survival in a National Multicentre Community Based Rheumatoid Arthritis Cohort
Abstract Number: 512

Memory B Cell Phenotypic and Gene Expression Profiling in Primary Sjogren’s Syndrome: Implications for Disease Diagnosis
Abstract Number: 156

Menopause and the Prevalence of Gout and Hyperuricemia: An Age-Matched Case Control Study
Abstract Number: 3

Mesenchymal Stem Cells Differentiate Into Osteoblasts in Response to Inflammation
Abstract Number: 257

Meta-Analysis of Four 12-Week Phase III Clinical Trials Investigating the Effect of TDT 064, a Transdermal Gel, in Osteoarthritis of the Knee
Abstract Number: 1697

Meta-Analysis of Malignancies, Serious Infections, and Serious Adverse Events with Tofacitinib or Biologic Treatment in Rheumatoid Arthritis Clinical Trials
Abstract Number: 352

Meta-Analysis: Influence of Methotrexate, Anti-TNF and Rituximab On the Immune Response to Influenza and Pneumococcal Vaccines in Patients with Rheumatoïd Arthritis
Abstract Number: 355

Metaanalysis of 5-Aminoimidazole-4-Carboxamide Ribonucleotide Transformylase (ATIC) 347C>G Polymorphism Affecting Methotrexate Efficacy and Toxicity in Rheumatoid Arthritis Patients
Abstract Number: 2665

Metabolic Reprogramming of Autoimmune T Cells in Rheumatoid Arthritis
Abstract Number: 2253

Metabolic Syndrome Is Not Only a Risk Factor for Cardiovascular Events in Systemic Lupus Erythematosus but Also Associated with Cumulative Organ Damage: A Cross-Sectional Analysis of 311 Patients
Abstract Number: 162

Metabolic Syndrome: The Genesis of Nephrolithiasis in Gout Patients
Abstract Number: 1095

Metal Concentrations in Patients with Failed Metal-On-Metal Hip Prostheses Determine the Inflammatory Phenotype in Peri-Implant Tissue
Abstract Number: 924

Methods to Link a U.S. Arthritis Cohort with Medicare Administrative Claims Data
Abstract Number: 2640

Methotrexate Adverse Events in a Cohort of US Veterans with Rheumatoid Arthritis
Abstract Number: 2001

Methotrexate and Injectable Tumor Necrosis Factor Alpha Inhibitor Adherence and Persistence in Children with Rheumatic Diseases
Abstract Number: 2170

Methotrexate and Interstitial Lung Disease in Rheumatoid Arthritis – A Systematic Literature Review and Meta-Analysis
Abstract Number: 2161

Methotrexate Polyglutamate Concentrations in Erythrocytes Are a Potential Tool for Therapeutic Drug Monitoring of Methotrexate Response in Rheumatoid Arthritis
Abstract Number: 438

Methyl Supplementation of Rheumatoid Arthritis Synovial Fibroblasts Regulates the Expression of Transcription Factors and Matrix Metalloproteinases
Abstract Number: 2346

MHC II-Independent Regulation of Intestinal Tregs
Abstract Number: 1670

Microarray Analysis for miRNA Expression in Juvenile Dermatomyositis (JDM)
Abstract Number: 1629

Microarray Analysis of Acute and Intercritical Gout
Abstract Number: 1002

Microrna Expression Profiles in Peripheral Blood Mononuclear Cells of Early Onset Psoriatic Arthritis
Abstract Number: 881

Microrna-155 Regulates Chemokines and Chemokine Receptors in Rheumatoid Arthritis Monocyte
Abstract Number: 2

Microrna-558 Regulates the Expression of Cyclooxygenase-2 and IL-1beta Responses in Human Articular Chondrocytes
Abstract Number: 1539

Microscopic Polyangiitis: A Large Single Center Series
Abstract Number: 805

Milnacipran Increases Cortical to Brainstem Connectivity During Pain in Fibromyalgia
Abstract Number: 802

Milnacipran Reduces Brain Activity During Pain in Fibromyalgia
Abstract Number: 244

Minimal Clinically Important Difference and Patient Acceptable Symptom State for the Oarsi-Omeract Intermittent and Constant OA Pain (ICOAP) Measure
Abstract Number: 1555

Minimal Clinically Important Difference for Seven Measures of Fatigue in Patients with Systemic Lupus Erythematosus – Results From a Swedish Setting
Abstract Number: 1785

MiR-30* Family Negatively Regulates B-Cell Activating Factor (BAFF) Synthesis in Rheumatoid Synoviocytes
Abstract Number: 2508

miR142-3p Interfers with T Cell Proliferation by Targeting the Expression of Garp in Patients with Rheumatoid Arthritis
Abstract Number: 2501

Mirorna Mir-150 Contributes to Chronic Kidney Injury in Lupus Nephritis by Increasing the Synthesis of Fibrotic Proteins Via Downregulation of SOCS1
Abstract Number: 2361

Misdiagnosis of Giant Cell Arteritis Presenting As Fever of Unknown Origin
Abstract Number: 1564

Misperceptions of FMS Patients about Their Disease
Abstract Number: 633

Missed Work Days in Systemic Lupus Erythematosus
Abstract Number: 1455

Mitochondrial Dysfunction in the Liver of Lupus-Prone MRL/Lpr Mice Prior to Disease Onset
Abstract Number: 889

Modeling Environmental and Genetic Determinants to Identify the Association of Risk Genes in Anti-Ro60-Mediated Injury: Relaxin Receptor I and Tumor Necrosis Factor
Abstract Number: 364

Moderate Rheumatoid Arthritis Despite Methotrexate Treatment: Risk of Radiographic Progression
Abstract Number: 2687

Modular Microarray Analysis Fails to Reveal a Significant Biological Effect of Vitamin D3 Treatment in Patients Participating in a Double-Blind Randomized Placebo-Controlled Trial of the Effect of Vitamin D3 On the Interferon Signature in Patients with Systemic Lupus Erythematosus
Abstract Number: 690

Molecular Analysis of 9G4+ Antibodies in Systemic Lupus Erythematosus
Abstract Number: 2529

Molecular Mechanism of IgG4 Class Switch Recombination in IgG4-Related Disease
Abstract Number: 2572

Molecular Signatures in SLE: Flare Vs. Infection
Abstract Number: 1408

Monitoring Patients with Systemic Lupus Erythematosus in Clinical Practice: Have You Already Checked the Vaccination Status in Your Patients?
Abstract Number: 2578

Monoclonal IgG Antibodies (ACPAs) From Synovial Fluid B Cells of Rheumatoid Arthritis Patients – Antigen-Driven Affinity Maturation and Cross Reactivity
Abstract Number: 872

Monocyte Chemoattractant Protein-1 and Eotaxin Are Associated with Parameters of Cardiac Dysfunction in Juvenile Dermatomyositis
Abstract Number: 137

Monosodium Urate Crystals Inhibit Tenocyte Viability and Function: Implications for Periarticular Involvement in Chronic Gout
Abstract Number: 472

More Positive Expectations of Treatment with Golimumab for Rheumatoid Arthritis Are Associated with Greater Improvement in Clinical Outcomes
Abstract Number: 1900

Mormed Project: A New 21^st Century Web Platform for Multilingual Communication in systemic Lupus Erythematosus and Antiphospholipid Syndrome
Abstract Number: 1975

Mortality After Fragility Hip Fracture in Middle Aged and Elderly Men and Women in Southern Norway
Abstract Number: 2559

Mortality in Patients with Psoriatic Arthritis Compared to Patients with Rheumatoid Arthritis, Psoriasis Alone, and the General Population
Abstract Number: 2603

Moving Into the Electronic Age: Validation of Rheumatology Self-Assessment Questionnaires On Tablet Computers
Abstract Number: 577

MRI of the Spine for Detection of Bone Spurs and Ankylosis in Patients with Ankylosing Spondylitis: Does MRI Offer Any Advantages Over Radiography?
Abstract Number: 991

MTHFR Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Associations with Intima Media Thickness Scores
Abstract Number: 2330

Mucosal-Associated Invariant T Cells Are Inactivated by IFNα and Reduced in Systemic Lupus Erythematosus
Abstract Number: 1908

Multinational Evidence-Based Recommendations for Diagnosis and Management of Gout: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3E Initiative
Abstract Number: 527

Multiplexed Nanostring Screening for Salivary Gland Viral Elements in Sjogren’s Syndrome
Abstract Number: 2414

Multisite Joint Pain and Fatigue: the Role of Pain Severity and Sleep Problems in Adults with Arthritis
Abstract Number: 1947

Muscle Wasting in HTNFtg Mice, an Animal Model for Rheumatoid Arthritis, Due to Increased Cathepsin L and LC3B Expression
Abstract Number: 2592

Musculoskeletal Ultrasound Objective Structured Clinical Examination : An Assessment of the Test
Abstract Number: 528

Mxa As a Biomarker for Systemic Interferon Type I Activation in Primary Sjögren′s Syndrome
Abstract Number: 289

Mycophenolate Mofetil and Abatacept Combination Therapy in Refractory Pediatric Systemic Lupus Erythematosus Nephritis
Abstract Number: 340

Myeloid Deletion of SIRT1 Aggravates Inflammatory Arthritis Via Nuclear Factor-Kappab Activation in Animal Model of Rheumatoid Arthritis
Abstract Number: 1674

Myeloid Related Proteins Induce Muscle Derived Inflammatory Mediators in Juvenile Dermatomyositis
Abstract Number: 2070

Myeloid-Derived Suppressor Cells Accumulated in Spleens of Mice with Collagen-Induced Arthritis and Inhibited Immune Response of CD4⁺ T Cells
Abstract Number: 1738

Myocardial Dysfunction and Valvulopathy Worsens with Time in Patients with Antiphospholipid Syndrome: A 10-Year Follow-up Study
Abstract Number: 711

Myopathy Is a Poor Prognostic Feature in Systemic Sclerosis: Results From the Canadian Scleroderma Research Group
Abstract Number: 1672

Myosin Skews Effector Immune Cells of Scurfy Mice to Target Muscles in an Adoptive Transfer Model of Myositis
Abstract Number: 1675

Myositis Autoimmunity and Muscle Weakness Are Linked to TNF-Alpha Suppression of Micrornas-1, 133, and 206 in Myoblasts and Myocytes
Abstract Number: 217

Myositis-Associated Usual Interstitial Pneumonia Has Better Survival Than Idiopathic Pulmonary Fibrosis

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].